Upgrades
According to Northcoast Research, the prior rating for Boeing Co (NYSE:BA) was changed from Sell to Neutral. In the second quarter, Boeing showed an EPS of $0.82, compared to $0.37 from the year-ago quarter. At the moment, the stock has a 52-week-high of $240.13 and a 52-week-low of $120.99. Boeing closed at $238.85 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
According to RBC Capital, the prior rating for New Relic Inc (NYSE:NEWR) was changed from Outperform to Sector Perform. New Relic earned $0.43 in the first quarter, compared to $0.26 in the year-ago quarter. The stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. At the end of the last trading period, New Relic closed at $83.98.
William Blair downgraded the previous rating for Symbotic Inc (NASDAQ:SYM) from Outperform to Market Perform. For the third quarter, Symbotic had an EPS of $0.07, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $64.14 and a 52-week-low of $8.75. At the end of the last trading period, Symbotic closed at $63.54.
According to DA Davidson, the prior rating for Symbotic Inc (NASDAQ:SYM) was changed from Buy to Neutral. For the third quarter, Symbotic had an EPS of $0.07, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $64.14 and a 52-week-low of $8.75. At the end of the last trading period, Symbotic closed at $63.54.
For New Relic Inc (NYSE:NEWR), Baird downgraded the previous rating of Outperform to Neutral. New Relic earned $0.43 in the first quarter, compared to $0.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. New Relic closed at $83.98 at the end of the last trading period.
For New Relic Inc (NYSE:NEWR), Credit Suisse downgraded the previous rating of Outperform to Neutral. For the first quarter, New Relic had an EPS of $0.43, compared to year-ago quarter EPS of $0.26. At the moment, the stock has a 52-week-high of $86.00 and a 52-week-low of $50.24. New Relic closed at $83.98 at the end of the last trading period.
Citigroup downgraded the previous rating for The Estee Lauder Companies Inc (NYSE:EL) from Buy to Neutral. Estee Lauder Cos earned $0.47 in the third quarter, compared to $1.90 in the year-ago quarter. The stock has a 52-week-high of $284.27 and a 52-week-low of $171.93. At the end of the last trading period, Estee Lauder Cos closed at $180.00.
See all analyst ratings downgrades.
Initiations
With a Buy rating, B. Riley Securities initiated coverage on Lilium NV (NASDAQ:LILM). The price target seems to have been set at $3.00 for Lilium. NoneThe stock has a 52-week-high of $3.25 and a 52-week-low of $0.37. At the end of the last trading period, Lilium closed at $1.37.
See all analyst ratings initiations.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
For Varonis Systems Inc (NASDAQ:VRNS), Craig-Hallum upgraded the previous rating of Hold to Buy. Varonis Systems earned $0.01 in the second quarter, compared to $0.00 in the year-ago quarter. The current stock performance of Varonis Systems shows a 52-week-high of $32.05 and a 52-week-low of $15.61. Moreover, at the end of the last trading period, the closing price was at $28.70.
Atlantic Equities upgraded the previous rating for The Goldman Sachs Group Inc (NYSE:GS) from Underweight to Neutral. For the second quarter, Goldman Sachs Gr had an EPS of $3.08, compared to year-ago quarter EPS of $7.73. The current stock performance of Goldman Sachs Gr shows a 52-week-high of $389.43 and a 52-week-low of $287.84. Moreover, at the end of the last trading period, the closing price was at $355.87.
For ResMed Inc (NYSE:RMD), RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the third quarter, ResMed had an EPS of $1.68, compared to year-ago quarter EPS of $1.32. The current stock performance of ResMed shows a 52-week-high of $247.51 and a 52-week-low of $202.04. Moreover, at the end of the last trading period, the closing price was at $222.35.
According to Barclays, the prior rating for Gap Inc (NYSE:GPS) was changed from Equal-Weight to Overweight. In the first quarter, Gap showed an EPS of $0.01, compared to $0.44 from the year-ago quarter. The current stock performance of Gap shows a 52-week-high of $15.49 and a 52-week-low of $7.22. Moreover, at the end of the last trading period, the closing price was at $10.30.
According to Barclays, the prior rating for Tapestry Inc (NYSE:TPR) was changed from Equal-Weight to Overweight. For the third quarter, Tapestry had an EPS of $0.78, compared to year-ago quarter EPS of $0.51. The current stock performance of Tapestry shows a 52-week-high of $47.48 and a 52-week-low of $27.54. Moreover, at the end of the last trading period, the closing price was at $43.15.
Barclays upgraded the previous rating for Bath & Body Works Inc (NYSE:BBWI) from Equal-Weight to Overweight. Bath & Body Works earned $0.33 in the first quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $49.55 and a 52-week-low of $30.52. Bath & Body Works closed at $37.06 at the end of the last trading period.
For American Eagle Outfitters Inc (NYSE:AEO), Barclays upgraded the previous rating of Equal-Weight to Overweight. In the first quarter, American Eagle Outfitters showed an EPS of $0.17, compared to $0.16 from the year-ago quarter. The current stock performance of American Eagle Outfitters shows a 52-week-high of $17.09 and a 52-week-low of $9.46. Moreover, at the end of the last trading period, the closing price was at $14.05.
Argus Research downgraded the previous rating for Canadian National Railway Co (NYSE:CNI) from Buy to Hold. In the second quarter, Canadian National Railway showed an EPS of $1.31, compared to $1.51 from the year-ago quarter. The current stock performance of Canadian National Railway shows a 52-week-high of $129.85 and a 52-week-low of $103.81. Moreover, at the end of the last trading period, the closing price was at $121.23.
According to Hovde Group, the prior rating for Valley National Bancorp (NASDAQ:VLY) was changed from Outperform to Market Perform. For the second quarter, Valley Ntl had an EPS of $0.28, compared to year-ago quarter EPS of $0.32. The current stock performance of Valley Ntl shows a 52-week-high of $13.06 and a 52-week-low of $6.38. Moreover, at the end of the last trading period, the closing price was at $10.26.
Citigroup downgraded the previous rating for Reata Pharmaceuticals Inc (NASDAQ:RETA) from Buy to Neutral. For the first quarter, Reata Pharmaceuticals had an EPS of $1.81, compared to year-ago quarter EPS of $1.33. At the moment, the stock has a 52-week-high of $167.24 and a 52-week-low of $18.47. Reata Pharmaceuticals closed at $165.58 at the end of the last trading period.
According to Loop Capital, the prior rating for MaxLinear Inc (NASDAQ:MXL) was changed from Buy to Hold. For the second quarter, MaxLinear had an EPS of $0.34, compared to year-ago quarter EPS of $1.11. The current stock performance of MaxLinear shows a 52-week-high of $43.66 and a 52-week-low of $22.25. Moreover, at the end of the last trading period, the closing price was at $24.67.
According to Wells Fargo, the prior rating for Chinook Therapeutics Inc (NASDAQ:KDNY) was changed from Overweight to Equal-Weight. Chinook Therapeutics earned $0.85 in the first quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.54 and a 52-week-low of $17.72. Chinook Therapeutics closed at $39.18 at the end of the last trading period.
According to Cantor Fitzgerald, the prior rating for Rivian Automotive Inc (NASDAQ:RIVN) was changed from Overweight to Neutral. Rivian Automotive earned $1.25 in the first quarter, compared to $1.43 in the year-ago quarter. The stock has a 52-week-high of $40.86 and a 52-week-low of $11.68. At the end of the last trading period, Rivian Automotive closed at $27.64.
B of A Securities downgraded the previous rating for Apellis Pharmaceuticals Inc (NASDAQ:APLS) from Buy to Neutral. In the second quarter, Apellis Pharmaceuticals showed an EPS of $1.02, compared to $1.46 from the year-ago quarter. The current stock performance of Apellis Pharmaceuticals shows a 52-week-high of $94.75 and a 52-week-low of $24.97. Moreover, at the end of the last trading period, the closing price was at $25.75.
Deutsche Bank downgraded the previous rating for ZoomInfo Technologies Inc (NASDAQ:ZI) from Buy to Hold. In the second quarter, ZoomInfo Technologies showed an EPS of $0.26, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $51.85 and a 52-week-low of $20.33. ZoomInfo Technologies closed at $25.57 at the end of the last trading period.
According to Barclays, the prior rating for Reata Pharmaceuticals Inc (NASDAQ:RETA) was changed from Overweight to Equal-Weight. In the first quarter, Reata Pharmaceuticals showed an EPS of $1.81, compared to $1.33 from the year-ago quarter. The stock has a 52-week-high of $167.24 and a 52-week-low of $18.47. At the end of the last trading period, Reata Pharmaceuticals closed at $165.58.
Keefe, Bruyette & Woods downgraded the previous rating for SoFi Technologies Inc (NASDAQ:SOFI) from Market Perform to Underperform. In the second quarter, SoFi Techs showed an EPS of $0.06, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.70 and a 52-week-low of $4.25. SoFi Techs closed at $11.45 at the end of the last trading period.
For Brown & Brown Inc (NYSE:BRO), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the second quarter, Brown & Brown showed an EPS of $0.68, compared to $0.51 from the year-ago quarter. The stock has a 52-week-high of $72.99 and a 52-week-low of $52.82. At the end of the last trading period, Brown & Brown closed at $70.45.
For Eastman Chemical Co (NYSE:EMN), Piper Sandler downgraded the previous rating of Overweight to Neutral. For the second quarter, Eastman Chemical had an EPS of $1.99, compared to year-ago quarter EPS of $2.83. At the moment, the stock has a 52-week-high of $102.12 and a 52-week-low of $69.91. Eastman Chemical closed at $85.58 at the end of the last trading period.
RF Lafferty initiated coverage on Polestar Automotive Holding UK PLC (NASDAQ:PSNY) with a Buy rating. The price target for Polestar Automotive is set to $9.00. For the first quarter, Polestar Automotive had an EPS of $0.01, compared to year-ago quarter EPS of $0.14. At the moment, the stock has a 52-week-high of $10.11 and a 52-week-low of $3.14. Polestar Automotive closed at $4.48 at the end of the last trading period.
With an Overweight rating, Cantor Fitzgerald initiated coverage on Health Catalyst Inc (NASDAQ:HCAT). The price target seems to have been set at $16.00 for Health Catalyst. In the first quarter, Health Catalyst showed an EPS of $0.05, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $18.28 and a 52-week-low of $6.41. At the end of the last trading period, Health Catalyst closed at $14.03.
Seaport Global initiated coverage on TopBuild Corp (NYSE:BLD) with a Buy rating. In the first quarter, TopBuild showed an EPS of $4.36, compared to $3.50 from the year-ago quarter. The current stock performance of TopBuild shows a 52-week-high of $280.67 and a 52-week-low of $140.93. Moreover, at the end of the last trading period, the closing price was at $273.93.
For Installed Building Products Inc (NYSE:IBP), Seaport Global initiated coverage, by setting the current rating at Buy. Installed Building Prods earned $2.15 in the first quarter, compared to $1.54 in the year-ago quarter. The current stock performance of Installed Building Prods shows a 52-week-high of $150.88 and a 52-week-low of $75.45. Moreover, at the end of the last trading period, the closing price was at $148.02.
With a Equal-Weight rating, Morgan Stanley initiated coverage on Vivid Seats Inc (NASDAQ:SEAT). The price target seems to have been set at $9.50 for Vivid Seats. Vivid Seats earned $0.15 in the first quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $9.89 and a 52-week-low of $6.29. At the end of the last trading period, Vivid Seats closed at $8.33.
